From GlobeNewswire: 2025-04-15 16:10:00

Milestone Scientific Inc. reports expanding the CompuFlo® Epidural System to more pain management clinics and surgery centers after favorable Medicare pricing decisions in multiple states. The company’s focus on streamlining operations and aligning cost structures in 2024 set the stage for growth in 2025. The CompuFlo system received favorable Medicare Part B physician payment rates in states like Florida, Texas, and more. The company also secured a contract for the Federal Supply Schedule to provide the system to federal medical facilities. Additionally, new partnerships and rollouts are driving adoption in both medical and dental segments. Financially, the company reported revenue of approximately $8.6 million in 2024, a decrease from $9.8 million in 2023, with improvements in gross profit and reduced operating losses.

Milestone Scientific Inc., a leader in computerized drug delivery instruments, saw a decline in revenue in 2024 but reported improvements in gross profit and reduced operating losses from 2023. The company launched an e-commerce platform for direct sales of the STA Single Tooth Anesthesia System® (STA) in the U.S., leading to increased revenue. International revenue declined due to market underperformance and shipping delays. The company’s operating loss improved to $6.8 million in 2024, with a net loss of approximately $4.7 million. Milestone Scientific remains focused on driving adoption of its technology in both medical and dental fields, with a strong outlook for 2025.



Read more at GlobeNewswire: Milestone Scientific Reports Year-End 2024 Financial